Pharma Tariff Tensions and Novo Drug Boost in Health Policy Showdown
Published on: April 3, 2026, 2:28 a.m. | Source: Devdiscourse
The global pharmaceutical landscape is facing significant changes, as President Trump's executive order enforces 100% tariffs on imported drugs unless companies produce domestically or agree to U.S. pricing deals. Meanwhile, the UK recommends Novo Nordisk's Wegovy for heart risk reduction, and various legal and market developments impact major drugmakers worldwide.
